NFGH
LEGN icon

Nan Fung Group Holdings’s Legend Biotech LEGN Stock Holding History

Nan Fung Group Holdings’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9,340
Closed -$435K – 52
2021
Q4 		$435K Buy
+9,340
New +$474K 0.13% 36

Other funds holding LEGN

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nan Fung Group Holdings's LEGN Position: Q1 2022 in Review

Nan Fung Group Holdings sold out of Legend Biotech (LEGN) in Q1 2022, closing a stake of 9,340 shares — an estimated $435K sold.

Nan Fung Group Holdings first reported a position in LEGN in Q4 2021 and held it in 1 quarter. The position peaked at $435K in Q4 2021. 141 funds tracked by Wall St. Rank hold LEGN as of Q1 2022.

  • Nan Fung Group Holdings reported no remaining Legend Biotech position as of Q1 2022 after selling out during the quarter.
  • Nan Fung Group Holdings sold 9,340 Legend Biotech shares in Q1 2022, an estimated $435K.
  • Nan Fung Group Holdings first reported a position in Legend Biotech in Q4 2021 and held it in 1 quarter.
  • Nan Fung Group Holdings's Legend Biotech position peaked at $435K in Q4 2021.
  • 141 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2022.

Based on Nan Fung Group Holdings's 13F filing for Q1 2022, filed 13 May 2022.